Compounds > silybin
Page last updated: 2024-08-23

silybin and tyrosine

silybin has been researched along with tyrosine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Hiramatsu, M; Ikejima, T; Lu, LL; Lu, P; Mamiya, T; Mouri, A; Nabeshima, T; Nagai, T; Niwa, M; Zou, LB1
Cheon, GJ; Choi, CM; Choi, SJ; Choi, YJ; Jeon, BS; Kim, CH; Kim, HR; Lee, JC; Rho, JK; Woo, SK1
Carratù, MR; de Bari, O; Diogo, CV; Ferri, D; Grattagliano, I; Liquori, A; Mastrodonato, M; Oliveira, PJ; Persichella, M; Portincasa, P; Wang, DQ1
Cheng, LH; Cui, S; Ge, CL; Guo, YT; Hao, HP; He, QX; Pan, XJ; Wang, GJ; Wang, H; Yan, TT; Zhang, PF; Zhou, JY1

Other Studies

4 other study(ies) available for silybin and tyrosine

ArticleYear
Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice.
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 331, Issue:1

    Topics: Amyloid beta-Peptides; Animals; Antioxidants; Drug Synergism; Inflammation Mediators; Male; Memory Disorders; Mice; Mice, Inbred ICR; Nitric Oxide Synthase Type II; Peptide Fragments; RNA, Messenger; Silybin; Silymarin; Tumor Necrosis Factor-alpha; Tyrosine; Up-Regulation

2009
Combined treatment with silibinin and epidermal growth factor receptor tyrosine kinase inhibitors overcomes drug resistance caused by T790M mutation.
    Molecular cancer therapeutics, 2010, Volume: 9, Issue:12

    Topics: Amino Acid Substitution; Animals; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Humans; Mice; Mutation; Protein Kinase Inhibitors; Protein Multimerization; Quinazolines; Signal Transduction; Silybin; Silymarin; Tyrosine; Xenograft Model Antitumor Assays

2010
A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes.
    World journal of gastroenterology, 2013, May-28, Volume: 19, Issue:20

    Topics: Animals; Biomarkers; Choline Deficiency; Diet, High-Fat; Disease Models, Animal; Fatty Liver; Glutathione; Glutathione Peroxidase; Keratin-18; Liver; Male; Malondialdehyde; Mitochondria, Liver; Mitochondrial Proteins; Nitroso Compounds; Oxidative Phosphorylation; Oxidative Stress; Phospholipids; Rats; Rats, Wistar; Silybin; Silymarin; Sulfhydryl Compounds; Thiobarbituric Acid Reactive Substances; Thioredoxins; Time Factors; Tyrosine; Vitamin E

2013
Silybin alleviates hepatic lipid accumulation in methionine-choline deficient diet-induced nonalcoholic fatty liver disease in mice via peroxisome proliferator-activated receptor α.
    Chinese journal of natural medicines, 2021, Volume: 19, Issue:6

    Topics: Animals; Choline; Diet; Lipid Metabolism; Liver; Methionine; Mice; Non-alcoholic Fatty Liver Disease; Oxazoles; PPAR alpha; Silybin; Tyrosine

2021